Minimizing Narcotic Use in Rhinoplasty: An Updated Narrative Review and Protocol

• Published in: Life (Basel, Switzerland) Vol. 14; no. 10; p. 1272
• Main Authors: Cheung, Madison Mai-Lan, Shah, Anil
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 07.10.2024; MDPI
• Subjects: Acetaminophen; Addictions; analgesia; Analgesics; anesthesia; Anesthetics; Bupivacaine; Celecoxib; Drug abuse; Drug dosages; Drug interactions; Drug overdose; Gabapentin; Lidocaine; Morphine; Narcotics; Nausea; Nonsteroidal anti-inflammatory drugs; opioid usage; opioid-sparing; Opioids; Pain management; Patient satisfaction; postoperative pain; Recovery (Medical); Review; Rhinoplasty; Side effects; Surgery; Vomiting; opioid-sparing; rhinoplasty; postoperative pain; analgesia; pain management; anesthesia; opioid usage
• ISSN: 2075-1729; 2075-1729
• DOI: 10.3390/life14101272

Opioids are commonly used to reduce pain after surgery; however, there are severe side effects and complications associated with opioid use, with addiction being of particular concern. Recent practice has shifted to reduce opioid consumption in surgery, although a specific protocol for rhinoplasty is still in progress. This paper aims to expand on the protocol previously established by the senior author based on updated evidence and details. This was accomplished by first high-lighting and summarizing analgesic agents with known opioid-reducing effects in the surgical field, with a particular focus on rhinoplasty, then compiling these analgesic options into a recommended protocol based on the most effective timing of administration (preoperative, intraoperative, postoperative). The senior author’s previous article on the subject was referenced to compile a list of analgesic agents of importance. Each analgesic agent was then searched in PubMed in conjunction with “rhinoplasty” or “opioid sparing” to find relevant primary sources and systematic reviews. The preferred analgesic agents included, as follows: preoperative, 1000 mg oral acetaminophen, 200 mg of oral celecoxib twice daily for 5 days, and 1200 mg oral gabapentin; intraoperative, 0.75 μg/kg of intravenous dexmedetomidine and 1–2 mg/kg injected lidocaine with additional 2–4 mg/kg per hour or 1.5 cc total bupivacaine nerve block injected along the infraorbital area bilaterally and in the subnasal region; and postoperatively, 5 mg oral acetaminophen and 400 mg of oral celecoxib. When choosing specific analgesic agents, considerations include potential side effects, contraindications, and the drug-specific mode of administration.